These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2535056

  • 1. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
    Linz W, Schölkens BA, Kaiser J, Just M, Qi BY, Albus U, Petry P.
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
    [Abstract] [Full Text] [Related]

  • 2. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W, Martorana PA, Schölkens BA.
    J Cardiovasc Pharmacol; 1990 Dec; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [Abstract] [Full Text] [Related]

  • 3. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
    Schölkens BA, Linz W.
    Clin Exp Hypertens A; 1988 Dec; 10(6):1259-70. PubMed ID: 2975971
    [Abstract] [Full Text] [Related]

  • 4. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.
    Schölkens BA, Linz W, König W.
    J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732
    [Abstract] [Full Text] [Related]

  • 5. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
    Linz W, Schölkens BA.
    J Cardiovasc Pharmacol; 1987 Dec; 10 Suppl 7():S75-82. PubMed ID: 2485067
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
    Linz W, Schölkens BA, Han YF.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 10():S91-9. PubMed ID: 2438498
    [Abstract] [Full Text] [Related]

  • 7. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA, Linz W.
    Klin Wochenschr; 1991 Dec; 69 Suppl 24():1-5. PubMed ID: 1865630
    [Abstract] [Full Text] [Related]

  • 8. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W, Wiemer G, Schölkens BA.
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [Abstract] [Full Text] [Related]

  • 9. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat.
    Massoudy P, Becker BF, Gerlach E.
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):632-9. PubMed ID: 7516015
    [Abstract] [Full Text] [Related]

  • 10. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Brunner F, Kukovetz WR.
    Circulation; 1996 Oct 01; 94(7):1752-61. PubMed ID: 8840871
    [Abstract] [Full Text] [Related]

  • 11. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W, Schölkens BA.
    J Cardiovasc Pharmacol; 1992 Oct 01; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
    Kozlovski VI, Lomnicka M, Jakubowski A, Chlopicki S.
    Pharmacol Rep; 2007 Oct 01; 59(4):421-7. PubMed ID: 17901571
    [Abstract] [Full Text] [Related]

  • 13. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    Schölkens BA, Linz W.
    Clin Physiol Biochem; 1990 Oct 01; 8 Suppl 1():33-43. PubMed ID: 2147878
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin?
    Shimada Y, Avkiran M.
    J Cardiovasc Pharmacol; 1996 Mar 01; 27(3):428-38. PubMed ID: 8907806
    [Abstract] [Full Text] [Related]

  • 15. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN, Carretero OA.
    Hypertension; 1996 Jan 01; 27(1):7-13. PubMed ID: 8591891
    [Abstract] [Full Text] [Related]

  • 16. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
    Carlsson L, Abrahamsson T.
    Eur J Pharmacol; 1989 Jul 18; 166(2):157-64. PubMed ID: 2792189
    [Abstract] [Full Text] [Related]

  • 17. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M, Pörsti I, Bara AT, Busse R.
    Br J Pharmacol; 1994 Jan 18; 111(1):238-44. PubMed ID: 8012702
    [Abstract] [Full Text] [Related]

  • 18. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC.
    Ann Thorac Surg; 1995 Sep 18; 60(3):789-92. PubMed ID: 7545893
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effect of imidaprilat and ramiprilat on broncho-constriction and hypotension induced by bradykinin in guinea pigs.
    Doi H, Narita H.
    Inflamm Res; 2000 Oct 18; 49(10):506-12. PubMed ID: 11089901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.